Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$37.17 USD
+0.81 (2.23%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $37.13 -0.04 (-0.11%) 7:18 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.59 | -13.56% |
Earnings Summary
For their last quarter, Celldex Therapeutics (CLDX) reported earnings of -$0.56 per share, beating the Zacks Consensus Estimate of $-0.67 per share. This reflects a positive earnings surprise of 16.42%. Look out for CLDX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 9.23%.
Earnings History
Price & Consensus
Zacks News for CLDX
Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
CLDX: What are Zacks experts saying now?
Zacks Private Portfolio Services